Adding to the string of US and international drugmakers investment in US production investment following a call from ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Laura McMullin as vice president of the trade ...

George Medicines, a UK biopharma focused on cardiometabolic diseases, has entered into an exclusive licensing and supply ...

NodThera, a privately-held biotech working in chronic inflammatory diseases through selective modulation of the NLRP3 ...

The European Commission has granted marketing authorization in the European Union (EU) for German pharma major Bayer’s Nubeqa ...

US biotech major Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing ...

South Korea’s biosimilar drug developer Samsung Bioepis today released its Third Quarter 2025 Market Report, marking the ...

The US Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu ...

Positive high-level results have been presented from the final overall survival (OS) analysis of the FLAURA2 Phase III trial.

Sweden’s OncoZenge has chosen Meribel Pharma Solutions—formerly Recipharm—to be the contract development and manufacturing ...

Swiss pharma giant Roche today reported mixed results from late-stage trials for its experimental drug astegolimab, which is ...

Denmark-based allergy immunotherapy specialist ALK Abello today announced that the UK’s National Institute for Health and ...